Ligands of purinergic receptors as novel analgesics

A. A Vassilevski

Genes & Cells ›› 2019, Vol. 14 ›› Issue (3) : 76 -76.

PDF
Genes & Cells ›› 2019, Vol. 14 ›› Issue (3) :76 -76. DOI: 10.23868/gc122365
Articles
oration

Ligands of purinergic receptors as novel analgesics

Author information +
History +
PDF

Abstract

Cite this article

Download citation ▾
A. A Vassilevski. Ligands of purinergic receptors as novel analgesics. Genes & Cells, 2019, 14(3): 76-76 DOI:10.23868/gc122365

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Grishin E.V., Savchenko G.A., Vassilevski A.A. et al. Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain. Ann. Neurol. 2010; 67(5): 680-3.

[2]

Kabanova N.V., Vassilevski A.A., Rogachevskaja O.A. et al. Modulation of P2X3 receptors by spider toxins. Biochim. Biophys. Acta 2012; 1818(11): 2868-75.

[3]

Oparin P.B., Nadezhdin K.D., Berkut A.A. et al. Structure of purotoxin-2 from wolf spider: modular design and membrane-assisted mode of action in arachnid toxins. Biochem. J. 2016; 473(19): 3113-26.

RIGHTS & PERMISSIONS

Eco-Vector

PDF

51

Accesses

0

Citation

Detail

Sections
Recommended

/